ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0325

Knee Symptom Phenotyping Incorporating Pain and Function across Different Levels of WOMAC Function in Two Cohorts: Data from the Multicenter Osteoarthritis Study (MOST) and the Osteoarthritis Initiative (OAI)

C. Kent Kwoh1, Amanda Nelson2, Rongrong Tang3, Edward J. Bedrick3, Yong Ge1, Yvonne Golightly4, Zong-Ming Li3, Jean Liew5, Xiaoxiao Sun1, Jeffrey Duryea6 and Tuhina Neogi5, 1The University of Arizona Arthritis Center, University of Arizona, Tucson, AZ, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3The University of Arizona Arthritis Center, University of Arizona, Tucson, 4University of Nebraska Medical Center, Omaha, NE, 5Boston University School of Medicine, Boston, MA, 6Brigham and Women’s Hospital, Boston, MA

Meeting: ACR Convergence 2025

Keywords: Epidemiology, functional status, Osteoarthritis, Outcome measures, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0306–0336) Osteoarthritis – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Knee pain and functional limitations are the most common symptoms of knee OA. Understanding the various patterns of symptoms (i.e., pain and function changes over time) can help identify individuals most in need of targeted interventions. Using OAI data, we have previously shown that there are distinct symptom trajectories for knees that start with no symptoms at baseline and there are specific predictors of a worse symptom trajectory. Our objective was to analyze knee symptoms among individuals with or at risk for knee OA with varying degrees of symptoms to identify temporal knee pain and function phenotypes using two large cohorts.

Methods: We selected 2965 knees from MOST, and 9491 knees from OAI that had the following knee pain/function measures available at baseline to develop the knee symptom phenotypes based upon trajectories of these measures over time: WOMAC function, WOMAC pain, and the Numerical Rating Scale (NRS) for knee pain severity. We used data from 0 to the 7th year in MOST, and from 0 to the 9th year in OAI to develop the trajectories. Knees that were already replaced at the baseline visit were excluded. Latent Class Mixed Models (LCMM) were employed to cluster the selected knees into distinct knee pain/function progression trajectories, while simultaneously using logistic regression to identify predictors associated with each trajectory. The response covariance matrix was allowed to be different for each latent class. We used tertiles of the baseline WOMAC function score as strata for LCMM analyses for each of the symptom measures.

Results: In both cohorts, two trajectories for each model were identified as optimal. For each tertile of baseline WOMAC function, the patterns of the trajectories were similar for each of the pain and function outcomes. As a sample illustration, the clusters for WOMAC function by tertile for MOST and OAI are shown in Figure 1. For the lowest tertile, there was a stable trajectory (blue) vs. a rapidly worsening trajectory (red). For the middle tertile, there was an improving trajectory (blue) vs. a worsening trajectory (red). For the highest tertile, both the red and blue clusters showed improving trajectories, but starting at different baseline scores. The ORs for being in the red (i.e., worse/worsening) vs. the blue (i.e., stable or improving) clusters for each tertile are summarized in Figure 2 for MOST and Figure 3 for OAI. The predictors in common across models associated with being in the red (i.e., worse) cluster were widespread pain, overweight/obese, higher Kellgren-Lawrence Grade (KLG), and more depressive symptoms (i.e., Center for Epidemiologic Studies Depression scale, CES-D).

Conclusion: For both MOST and OAI, similar symptom trajectories were identified when the cohorts were stratified using the tertile of the baseline WOMAC function score. We have also identified readily assessable predictors of the worse symptom trajectories. The trajectories with worse symptom progression may represent a group to target with interventions earlier in their disease course.

Supporting image 1Figure 1. Knee symptom phenotyping by tertiles of baseline WOMAC function score for OAI and MOST

The average trajectory (solid line) and confidence intervals (dashed lines) for WOMAC function are shown. The left column shows the trajectory results for OAI, and the right column show the trajectory results for MOST. Each row shows the tertile-specific cluster trajectories by strata of baseline WOMAC function score by tertile. The left-sided y-axis is the latent process WOMAC function score transformed using the link function. The right-sided y-axis is the actual WOMAC function score.

Supporting image 2Figure 2. Summary of the predictors for being in the Red Trajectory (i.e., worse/worsening) vs. the Blue Trajectory (i.e., stable/improving) [in Figure 1] by tertiles of baseline WOMAC function score for MOST

WSP = widespread pain; KL = Kellgren-Lawrence; CES-D_SD = Center for Epidemiologic Studies Depression scale by standard deviation

OR of KL 3, 4 for the highest tertile is 99.48, with CI [5.26, 1881.83]. This information was not included in the plot due to scale issues.

Supporting image 3Figure 3. Summary of the predictors for being in the Red Trajectory (i.e., worse/worsening) vs. the Blue Trajectory (i.e., stable/improving) [in Figure 1] by tertiles of baseline WOMAC function score for OAI

WSP = widespread pain; KL = Kellgren-Lawrence; CES-D_SD = Center for Epidemiologic Studies Depression scale by standard deviation


Disclosures: C. Kwoh: Apos Health, 1, 2, Express Scripts, 1, 2, Kolon Tissue Gene, 2, Mobieus Sun, 1, 2, TLC, 1, 2, Xalud, 1, 2; A. Nelson: Novo Nordisk, 1; R. Tang: None; E. Bedrick: None; Y. Ge: None; Y. Golightly: None; Z. Li: None; J. Liew: None; X. Sun: None; J. Duryea: None; T. Neogi: None.

To cite this abstract in AMA style:

Kwoh C, Nelson A, Tang R, Bedrick E, Ge Y, Golightly Y, Li Z, Liew J, Sun X, Duryea J, Neogi T. Knee Symptom Phenotyping Incorporating Pain and Function across Different Levels of WOMAC Function in Two Cohorts: Data from the Multicenter Osteoarthritis Study (MOST) and the Osteoarthritis Initiative (OAI) [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/knee-symptom-phenotyping-incorporating-pain-and-function-across-different-levels-of-womac-function-in-two-cohorts-data-from-the-multicenter-osteoarthritis-study-most-and-the-osteoarthritis-initiati/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/knee-symptom-phenotyping-incorporating-pain-and-function-across-different-levels-of-womac-function-in-two-cohorts-data-from-the-multicenter-osteoarthritis-study-most-and-the-osteoarthritis-initiati/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology